Table 1. Comparison of the diagnostic performance in detecting recurrence of a rise in blood CEA level above a threshold of 5μg/L in relation to i) all CEA measurements taken prior to diagnosis of recurrence and ii) the final CEA measurement taken prior to diagnosis of recurrence.
Final CEA measurement (95% CI) | All CEA measurements (95% CI) | |
---|---|---|
Sensitivity | 49.0% (39.2–59.0%) | 50.0% (40.1–59.9%) |
Specificity | 97.5% (95.5–98.6%) | 93.3% (90.6–95.3%) |
Positive predictive value | 81.0% (68.7–89.4%) | 61.9% (50.6–72.1%) |
Negative predictive value | 89.8% (86.8–92.2%) | 89.6% (86.5–92.0%) |
Positive likelihood ratio | 19.5 (10.8–35.3) | 7.5 (5.1–11.0) |
Negative likelihood ratio | 0.52 (0.43–0.63) | 0.54 (0.44–0.65) |